Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41 | 0 | 1 | 1 | 65 |
| TOTAL | $144 | $0 | $1 | $1 | $89 |
| Non-Current Assets | |||||
| PPE Net | 26 | N/A | N/A | N/A | 32 |
| Other Non-Current Assets | 256 | 0 | 0 | 0 | 63 |
| TOTAL | $282 | $N/A | $N/A | $N/A | $95 |
| Total Assets | $425 | $0 | $1 | $1 | $184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 150 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 695 | 15 | 14 | 13 | 318 |
| Accrued Expenses | 49 | N/A | N/A | N/A | 23 |
| Other current liabilities | 32 | N/A | N/A | N/A | N/A |
| TOTAL | $925 | $15 | $14 | $13 | $340 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,925 | 0 | 0 | 0 | 0 |
| TOTAL | $1,954 | $N/A | $N/A | $N/A | $19 |
| Total Liabilities | $2,879 | $15 | $14 | $13 | $360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,278 | 5,500 | 5,500 | 5,500 | 5,500 |
| Common Shares | 27 | 6 | 6 | 6 | 18 |
| Retained earnings | -6,395 | -80 | -78 | -76 | -2,925 |
| TOTAL | $-2,454 | $-15 | $-13 | $-11 | $-176 |
| Total Liabilities And Equity | $426 | $0 | $1 | $1 | $184 |